Catalyst Wire Dossier Catalyst Wire Dossier

Levetiracetam Extended-Release

levetiracetam · Omnivium Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Levetiracetam Extended-Release, covering 2020-06-11 to 2022-07-20. Get the full timeline:

Most recent: FDA Approved: LEVETIRACETAM EXTENDED-RELEASE — Supplemental Application (Omnivium Pharmaceuticals LLC)

See pricing